PRESENCE OF ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION

被引：0
|
作者：
Eng, G. [1 ,2 ]
Fana, V. [3 ]
Omerovic, E. [4 ]
Hojsgaard, P. [5 ]
Lindegaard, H. M. [6 ]
Jensen, E. K. [7 ]
Bouchelouche, P. N. [1 ]
机构：
[1] Copenhagen Univ Hosp Koge, Koge, Region Zealand, Denmark
[2] Copenhagen Univ Hosp Frederiksberg & Bispebjerg, Dept Rheumatol, Parker Inst, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Glostrup, Denmark
[4] Copenhagen Univ Hosp Frederiksberg & Bispebjerg, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Gentofte, Denmark
[6] Odense Univ Hosp, DK-5000 Odense, Denmark
[7] Copenhagen Univ Hosp Holbaek, Holbaek, Denmark
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：230 / 230
页数：1
相关论文
共 50 条
  • [21] Achieving Clinical Remission for Patients With Rheumatoid Arthritis
    Aletaha, Daniel
    Smolen, Josef S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (05): : 457 - 458
  • [22] Dosing patterns and costs of adalimumab, etanercept, and infliximab among patients with rheumatoid arthritis
    Engel-Nitz, N. M.
    Huang, X.
    Globe, D.
    Baumgartner, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 260 - 260
  • [23] SOLUBLE FAS/FASL LEVELS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB AND ADALIMUMAB
    Terenzi, R.
    Guiducci, S.
    Nacci, F.
    Romano, E.
    Manetti, M.
    Peruzzi, F.
    Bruni, C.
    Bartoli, F.
    Matucci-Cerinic, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 522 - 522
  • [24] Antinuclear antibodies (ANA) in rheumatoid arthritis patients treated with infliximab
    Bonilla, G
    Gamero, F
    Fernandez-Melón, J
    Alvarez-Doformo, R
    Balsa, A
    Martín-Mola, E
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 433 - 433
  • [25] Anticardiolipin antibodies in patients with rheumatoid arthritis and spondyloarthropathies treated with infliximab
    Gómez-Puerta, JA
    Hernández, MV
    Reverter, JC
    Salvador, G
    Vázquez, I
    Graell, E
    Rodriguez-Cros, JR
    Gómez-Centeno, A
    Cañete, JD
    Sanmarti, R
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 253 - 253
  • [26] A difference in effectiveness between infliximab, etanercept and adalimumab in patients with rheumatoid arthritis.
    Kievit, Wietske
    Fransen, Jaap
    Kuper, Ina H.
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    De Rooij, Dirk jan R. A. M.
    de Gendt, Carla M.
    Ronday, Karel H.
    Brus, Herman L. M.
    van Ooijen, Piet C. M.
    van Riel, Piet C. L. M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S309 - S310
  • [27] Remission and major clinical response in active rheumatoid arthritis (RA) patients after adalimumab (Humira®) treatment
    Burmester, G. M.
    Wordsworth, P.
    McKenna, F.
    Farraccioli, G. F.
    Flipo, R. -M.
    Kary, S.
    Kupper, H.
    RHEUMATOLOGY, 2007, 46 : I28 - I29
  • [28] ADALIMUMAB DOSE REDUCTION IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHROPATHY AND ANKYLOSING SPONDYLITIS PATIENTS IN SUSTAINED CLINICAL REMISSION
    Borras-Blasco, J.
    Gracia-Perez, A.
    Antonio Perez-Torres, A.
    Castera, D. -E.
    Abad, J.
    Rosique-Robles, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 241 - 241
  • [29] Remission and major clinical response in patients with active rheumatoid arthritis (RA) after treatment with adalimumab (Humira®).
    Burmester, G. M.
    Ferraccioli, G. F.
    Flipo, R-M
    Kary, S.
    Kupper, H.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S377 - S377
  • [30] Low Inflammation on Magnetic Resonance Imaging in Patients with Rheumatoid Arthritis That Achieved Sustained Clinical Remission on Adalimumab
    Emery, Paul
    Burmester, Gerd R.
    Naredo, Esperanza
    Galindo, Ivan Lagunes
    Zhang, Ying
    Wang, Xin
    Hojnik, Maja
    Conaghan, Philip G.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345